

Highlights from the 2022 Texas MPN Workshop: early intervention, disease progression & future targets
Oct 7, 2022
Andrew Ku, an expert in myeloproliferative neoplasms (MPNs), discusses disease progression in MPNs, the importance of early intervention, and future targets at the 2022 Texas MPN Workshop. Topics covered include impeding disease progression, inflammation and TNF production in MPN patients, and the correlation between monocyte activity and disease progression.
Chapters
Transcript
Episode notes